Me medicine vs. we medicine, reclaiming biotechnology for the common good, Donna Dickenson
Type
Label
Me medicine vs. we medicine, reclaiming biotechnology for the common good, Donna Dickenson
Language
eng
Bibliography note
Includes bibliographical references and index
Index
index present
Literary Form
non fiction
Main title
Me medicine vs. we medicine
Nature of contents
bibliography
Oclc number
810409773
Responsibility statement
Donna Dickenson
Sub title
reclaiming biotechnology for the common good
Summary
Personalized healthcare -- or what the award-winning author Donna Dickenson calls "Me Medicine" -- is radically transforming our longstanding "one-size-fits-all" model. Technologies such as direct-to-consumer genetic testing, pharmacogenetically developed therapies in cancer care, private umbilical cord blood banking, and neurocognitive enhancement claim to cater to an individual's specific biological character, and, in some cases, these technologies have shown powerful potential. Yet in others they have produced negligible or even negative results. Whatever is behind the rise of Me Medicine, it isn't just science. So why is Me Medicine rapidly edging out We Medicine, and how has our commitment to our collective health suffered as a result?
resource.variantTitle
Me medicine versus we medicine
Classification
Creator
Subject
Mapped to
Incoming Resources
- Has instance1